Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Paper
  • Published:

Effect of orlistat treatment on body composition and resting energy expenditure during a two-year weight-reduction programme in obese Finns

Abstract

OBJECTIVE: To examine the effect of orlistat (Xenical™) treatment on body composition and resting energy expenditure (REE) during a 2 y weight-reduction programme in obese Finns.

SUBJECTS: Of initially 96 obese subjects who participated in the weight-reduction programme, those 72 subjects (13 men, 59 women, body mass index (BMI) 35.9±3.9 kg/m2, age 43.4±6.0 y, mean±s.d.) with the complete set of data for 2 y were included in the study.

DESIGN: After a 4-week lead-in period, subjects were randomized with either orlistat 120 mg t.i.d. or placebo t.i.d. in conjunction with a mildly hypoenergetic balanced diet for 1 y. This was followed by 1 y double-blind period with the subjects within each treatment group re-assigned to receive orlistat 120 mg t.i.d. or placebo t.i.d. in conjunction with a weight maintenance diet.

MEASUREMENTS: Body composition and REE were measured after an overnight fast by a bioelectrical impedance method and indirect calorimeter, respectively. The measurements were performed at the beginning and at 3, 6, 12 and 24 months.

RESULTS: During the first year, the orlistat-treated group had greater reduction of body weight and fat mass but not of fat-free mass or REE as compared to placebo. During the second year, orlistat treatment was associated with smaller regain of body weight and fat mass with no significant differences in the changes of fat-free mass or REE as compared to placebo.

CONCLUSION: In addition to better weight loss and maintenance of reduced weight, orlistat treatment is associated with beneficial changes in body composition but with no excess decrease in resting energy expenditure as compared to that achieved during placebo with a dietary therapy alone.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1

Similar content being viewed by others

References

  1. Weinsier RL, Bracco D, Schutz Y . Predicted effects of small decreases in energy expenditure on weight gain in adult women Int J Obes Relat Metab Disord 1993 17: 693–700.

    CAS  PubMed  Google Scholar 

  2. Ravussin E, Lillioja S, Knowler WC, Cristin L, Freymond D, Abbott WGH, Boyce V, Howard BV, Bogardus C . Reduced rate of energy expenditure as a risk factor for body-weight gain New Engl J Med 1988 318: 467–472.

    Article  CAS  Google Scholar 

  3. Saltzman E, Roberts SB . The role of energy expenditure in energy regulation: findings from a decade of research Nutr Rev 1995 53: 209–220.

    Article  CAS  Google Scholar 

  4. Ravussin E, Swinburn BA . Metabolic predictors of obesity: cross-sectional versus longitudinal data Int J Obes Relat Metab Disord 1993 17 (Suppl 3): S28–S31.

    PubMed  Google Scholar 

  5. Cunningham JJ . Body composition as a determinant of energy expenditure: a synthetic review and a proposed general prediction equation Am J Clin Nutr 1991 54: 963–969.

    Article  CAS  Google Scholar 

  6. Karhunen L, Franssila-Kallunki A, Rissanen A, Kervinen K, Kesäniemi YA, Uusitupa M . Determinants of resting energy expenditure in obese non-diabetic caucasian women Int J Obes Relat Metab Disord 1997 21: 197–202.

    Article  CAS  Google Scholar 

  7. Nelson KM, Weinsier RL, Long CL, Schutz Y . Prediction of resting energy expenditure from fat-free mass and fat mass Am J Clin Nutr 1992 56: 848–856.

    Article  CAS  Google Scholar 

  8. Leibel RL, Rosenbaum M, Hirsch J . Changes in energy expenditure resulting from altered body weight New Engl J Med 1995 332: 621–628.

    Article  CAS  Google Scholar 

  9. Guerciolini R . Mode of action of orlistat Int J Obes Relat Metab Disord 1997 21 (Suppl 3): S12–S23.

    CAS  PubMed  Google Scholar 

  10. Uusitupa M . New aspects in the management of obesity: operation and the impact of lipase inhibitors Curr Opin Lipidol 1999 10: 3–7.

    Article  CAS  Google Scholar 

  11. Sjöström L, Rissanen A, Andersen T, Boldrin M, Golay A, Koppeschaar HP, Krempf M . Randomised placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients. European Multicentre Orlistat Study Group Lancet 1998 352: 167–172.

    Article  Google Scholar 

  12. Ferrannini E . The theoretical bases of indirect calorimetry: a review Metabolism 1988 37: 287–301.

    Article  CAS  Google Scholar 

  13. Ravussin E, Bogardus C . Relationship of genetics, age, and physical fitness to daily energy expenditure and fuel utilization Am J Clin Nutr 1989 49: 968–975.

    Article  CAS  Google Scholar 

  14. James WPT, Schofield EC . Human Energy Requirements: A Manual for Planners and Nutritionalists Published by arrangement with the Food and Agriculture Organization of the United Nations. Oxford University Press: Oxford 1990.

  15. Drent ML, Larsson I, William-Olsson T, Quaade F, Cxubayko F, von Bergmann K, Stobel W, Sjöström L, van der Veen EA . Orlistat (Ro 18-0647), a lipase inhibitor, in the treatment of human obesity: a multiple dose study Int J Obes Relat Metab Disord 1995 19: 221–226.

    CAS  PubMed  Google Scholar 

  16. James WP, Avenell A, Broom J, Whitehead J . A one-year trial to assess the value of orlistat in the management of obesity Int J Obes Relat Metab Disord 1997 21 (Suppl 3): S24–S30.

    CAS  PubMed  Google Scholar 

  17. Davidson MH, Hauptman J, DiGirolamo M, Foreyt JP, Halsted CH, Heber D, Heimburger DC, Lucas CP, Robbins DC, Chung J, Heymsfield SB . Weight control and risk factor reduction in obese subjects treated for 2 y with orlistat: a randomized controlled trial JAMA 1999 281: 235–242.

    Article  CAS  Google Scholar 

  18. Drent ML, Popp-Snijders C, Ader HJ, Jansen JB, van der Veen EA . Lipase inhibition and hormonal status, body composition and gastrointestinal processing of a liquid high-fat mixed meal in moderately obese subjects Obes Res 1995 3: 573–581.

    Article  CAS  Google Scholar 

  19. Forster JL, Jeffery RW, Snell MK . One-year follow-up study to a worksite weight control program Prev Med 1988 17: 129–133.

    Article  CAS  Google Scholar 

  20. Kramer FM, Jeffery RW, Forster JL, Snell MK . Long-term follow-up of behavioral treatment for obesity: patterns of weight regain among men and women Int J Obes 1989 13: 123–136.

    CAS  Google Scholar 

  21. Hill JO, Hauptman J, Anderson JW, Fujioka K, O'NeilPM, Smith DK, Zavoral JH, Aronne LJ . Orlistat a lipase inhibitor, for weight maintenance after conventional dieting: a 1-y study Am J Clin Nutr 1999 69: 1108–1116.

    Article  CAS  Google Scholar 

  22. Ravussin E, Burnand B, Schutz Y, Jequier E . Energy expenditure before and during energy restriction in obese patients Am J Clin Nutr 1985 41: 753–759.

    Article  CAS  Google Scholar 

  23. Kinney JM . Influence of altered body weight on energy expenditure Nutr Rev 1995 53: 265–268.

    Article  CAS  Google Scholar 

  24. Van Gaal LF, Vansant GA, De Leeuw IH . Factors determining energy expenditure during very-low-calorie diets Am J Clin Nutr 1992 56: 224S–229S.

    Article  CAS  Google Scholar 

  25. Deurenberg P . Limitations of the bioelectrical impedance method for the assessment of body fat in severe obesity Am J Clin Nutr 1996 64 (Suppl): 449S–452S.

    Article  CAS  Google Scholar 

  26. Kushner RF, Kunigk A, Alspaugh M, Andronis PT, Leitch CA, Schoeller DA . Validation of bioelectrical-impedance analysis as a measurement of change in body composition in obesity Am J Clin Nutr 1990 52: 219–223.

    Article  CAS  Google Scholar 

  27. Utter AC, Nieman DC, Ward AN, Butterworth DE . Use of the leg-to-leg bioelectrical impedance method in assessing body-composition change in obese women Am J Clin Nutr 1999 69: 603–607.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The authors wish to thank Ms Erja Kinnunen, Ms Marita Lauronen, Ms Irja Lyytikäinen, Ms Auli Paananen, Ms Sirpa Sarlio-Lähteenkorva and Ms Helena Åkerfelt for expert help in this study. The study was supported by a grant from F Hoffman-La Roche Ltd to the Universities of Kuopio and Helsinki, and by grants from the Kuopio University Hospital, and the Academy of Finland, Research Council for Health.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to L Karhunen.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Karhunen, L., Franssila-Kallunki, A., Rissanen, P. et al. Effect of orlistat treatment on body composition and resting energy expenditure during a two-year weight-reduction programme in obese Finns. Int J Obes 24, 1567–1572 (2000). https://doi.org/10.1038/sj.ijo.0801443

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.ijo.0801443

Keywords

This article is cited by

Search

Quick links